跳至主要内容
临床试验/EUCTR2013-000949-39-PL
EUCTR2013-000949-39-PL进行中(未招募)不适用

An Observational Study Providing 12 Months of Safety Follow-Up from First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU)

Smith & Nephew Inc.0 个研究点目标入组 440 人开始时间: 2013年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
440

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - The informed consent document must be read, signed, and dated by the subject or the subject’s legally authorized representative before conducting any study procedures or exams. A photocopy of the signed informed consent document must be provided to the subject, and the original signed document placed in the subject’s chart.
  • - Subject was randomized in 802-247-09-032 and received at least one application of test article.
  • - Subject has ended their participation in 802-247-09-032 by virtue of completing the study, or by dropping out prior to completion.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 264
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 176

排除标准

  • Subjects who refuse to provide written informed consent for this study will be excluded from this study.

研究者

发起方
Smith & Nephew Inc.

相似试验